ID MET18_HUMAN Reviewed; 372 AA. AC O95568; B2R9T5; DT 25-JUL-2006, integrated into UniProtKB/Swiss-Prot. DT 01-MAY-1999, sequence version 1. DT 24-JAN-2024, entry version 159. DE RecName: Full=Histidine protein methyltransferase 1 homolog {ECO:0000305|PubMed:33693809}; DE EC=2.1.1.85 {ECO:0000269|PubMed:33693809, ECO:0000269|PubMed:35674491}; DE AltName: Full=Arsenic-transactivated protein 2 {ECO:0000303|Ref.1}; DE Short=AsTP2 {ECO:0000303|Ref.1}; DE AltName: Full=Methyltransferase-like protein 18 {ECO:0000312|HGNC:HGNC:28793}; GN Name=METTL18 {ECO:0000303|PubMed:33693809, GN ECO:0000312|HGNC:HGNC:28793}; GN Synonyms=ASTP2 {ECO:0000303|Ref.1}, C1orf156 GN {ECO:0000312|HGNC:HGNC:28793}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RA Wu S.-H., Cheng J., Zheng Y.-J., Liu Y., Zhang Y.-X.; RT "Cloning and identification of human AsTP2 gene transactivated by arsenic RT trioxide."; RL Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RA Rhodes S.; RL Submitted (FEB-1999) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RA Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.; RT "Cloning of human full open reading frames in Gateway(TM) system entry RT vector (pDONR201)."; RL Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Subthalamic nucleus; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16710414; DOI=10.1038/nature04727; RA Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., RA Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., RA Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K., RA Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C., RA Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W., RA Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., RA Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., RA Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., RA Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., RA Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H., RA Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L., RA Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J., RA Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., RA Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K., RA Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R., RA Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M., RA Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S., RA Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J., RA Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., RA McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N., RA Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V., RA Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J., RA Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E., RA Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S., RA Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., RA White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., RA Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., RA Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., RA Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.; RT "The DNA sequence and biological annotation of human chromosome 1."; RL Nature 441:315-321(2006). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [7] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Colon; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [8] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-72, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Embryonic kidney; RX PubMed=17525332; DOI=10.1126/science.1140321; RA Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., RA Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., RA Gygi S.P., Elledge S.J.; RT "ATM and ATR substrate analysis reveals extensive protein networks RT responsive to DNA damage."; RL Science 316:1160-1166(2007). RN [9] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=18669648; DOI=10.1073/pnas.0805139105; RA Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., RA Elledge S.J., Gygi S.P.; RT "A quantitative atlas of mitotic phosphorylation."; RL Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). RN [10] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-72 AND SER-77, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Erythroleukemia; RX PubMed=23186163; DOI=10.1021/pr300630k; RA Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., RA Mohammed S.; RT "Toward a comprehensive characterization of a human cancer cell RT phosphoproteome."; RL J. Proteome Res. 12:260-271(2013). RN [11] RP FUNCTION, AND INTERACTION WITH GRWD1; HSP70 AND HSP90 FAMILY MEMBERS. RX PubMed=23349634; DOI=10.1371/journal.pgen.1003210; RA Cloutier P., Lavallee-Adam M., Faubert D., Blanchette M., Coulombe B.; RT "A newly uncovered group of distantly related lysine methyltransferases RT preferentially interact with molecular chaperones to regulate their RT activity."; RL PLoS Genet. 9:E1003210-E1003210(2013). RN [12] RP FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH RPL3, SUBCELLULAR LOCATION, RP METHYLATION AT HIS-154, MOTIF, AND MUTAGENESIS OF HIS-154; ASP-217 AND RP 250-LYS-ARG-251. RX PubMed=33693809; DOI=10.1093/nar/gkab088; RA Malecki J.M., Odonohue M.F., Kim Y., Jakobsson M.E., Gessa L., Pinto R., RA Wu J., Davydova E., Moen A., Olsen J.V., Thiede B., Gleizes P.E., RA Leidel S.A., Falnes P.O.; RT "Human METTL18 is a histidine-specific methyltransferase that targets RPL3 RT and affects ribosome biogenesis and function."; RL Nucleic Acids Res. 49:3185-3203(2021). RN [13] RP FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF 193-ASP--GLY-197. RX PubMed=35674491; DOI=10.7554/elife.72780; RA Matsuura-Suzuki E., Shimazu T., Takahashi M., Kotoshiba K., Suzuki T., RA Kashiwagi K., Sohtome Y., Akakabe M., Sodeoka M., Dohmae N., Ito T., RA Shinkai Y., Iwasaki S.; RT "METTL18-mediated histidine methylation of RPL3 modulates translation RT elongation for proteostasis maintenance."; RL Elife 11:0-0(2022). RN [14] {ECO:0007744|PDB:4RFQ} RP X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 63-372 IN COMPLEX WITH RP S-ADENOSYL-L-METHIONINE, AND REGION. RA Ravichandran M., Tempel W., Li Y., Walker J.R., Bountra C., RA Arrowsmith C.H., Edwards A.M., Brown P.J., Hong B.S.; RT "Human Methyltransferase-Like 18."; RL Submitted (SEP-2014) to the PDB data bank. CC -!- FUNCTION: Protein-L-histidine N-tele-methyltransferase that CC specifically monomethylates RPL3, thereby regulating translation CC elongation (PubMed:23349634, PubMed:33693809, PubMed:35674491). CC Histidine methylation of RPL3 regulates translation elongation by CC slowing ribosome traversal on tyrosine codons: slower elongation CC provides enough time for proper folding of synthesized proteins and CC prevents cellular aggregation of tyrosine-rich proteins CC (PubMed:35674491). {ECO:0000269|PubMed:23349634, CC ECO:0000269|PubMed:33693809, ECO:0000269|PubMed:35674491}. CC -!- CATALYTIC ACTIVITY: CC Reaction=L-histidyl-[protein] + S-adenosyl-L-methionine = H(+) + CC N(tele)-methyl-L-histidyl-[protein] + S-adenosyl-L-homocysteine; CC Xref=Rhea:RHEA:19369, Rhea:RHEA-COMP:9745, Rhea:RHEA-COMP:11600, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:16367, ChEBI:CHEBI:29979, CC ChEBI:CHEBI:57856, ChEBI:CHEBI:59789; EC=2.1.1.85; CC Evidence={ECO:0000269|PubMed:33693809, ECO:0000269|PubMed:35674491}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19370; CC Evidence={ECO:0000269|PubMed:33693809, ECO:0000269|PubMed:35674491}; CC -!- SUBUNIT: Interacts with GRWD1 and members of the heat shock protein 90 CC and 70 families; these proteins may possibly be methylation substrates CC for the enzyme. {ECO:0000269|PubMed:23349634}. CC -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:33693809}. CC Nucleus {ECO:0000269|PubMed:33693809}. Nucleus, nucleolus CC {ECO:0000269|PubMed:33693809}. CC -!- PTM: Monomethylated at His-154 through automethylation CC (PubMed:33693809). Automethylation at His-154 positively regulates the CC methyltransferase activity toward RPL3 (PubMed:33693809). Probably CC methylated on other residues (PubMed:33693809). CC {ECO:0000269|PubMed:33693809}. CC -!- SIMILARITY: Belongs to the methyltransferase superfamily. METTL18 CC family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AY744366; AAU95377.1; -; mRNA. DR EMBL; AL035369; CAA23019.1; -; mRNA. DR EMBL; CR450330; CAG29326.1; -; mRNA. DR EMBL; AK313909; BAG36632.1; -; mRNA. DR EMBL; AL021940; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471067; EAW90861.1; -; Genomic_DNA. DR EMBL; BC008679; AAH08679.1; -; mRNA. DR CCDS; CCDS1284.1; -. DR RefSeq; NP_001307128.1; NM_001320199.1. DR RefSeq; NP_001307130.1; NM_001320201.1. DR RefSeq; NP_219486.1; NM_033418.3. DR RefSeq; XP_006711690.1; XM_006711627.3. DR PDB; 4RFQ; X-ray; 2.40 A; A=63-372. DR PDBsum; 4RFQ; -. DR AlphaFoldDB; O95568; -. DR SMR; O95568; -. DR BioGRID; 124936; 78. DR IntAct; O95568; 7. DR MINT; O95568; -. DR STRING; 9606.ENSP00000307975; -. DR CarbonylDB; O95568; -. DR iPTMnet; O95568; -. DR PhosphoSitePlus; O95568; -. DR BioMuta; METTL18; -. DR EPD; O95568; -. DR jPOST; O95568; -. DR MassIVE; O95568; -. DR MaxQB; O95568; -. DR PaxDb; 9606-ENSP00000307975; -. DR PeptideAtlas; O95568; -. DR ProteomicsDB; 50944; -. DR Pumba; O95568; -. DR Antibodypedia; 34368; 49 antibodies from 12 providers. DR DNASU; 92342; -. DR Ensembl; ENST00000303469.6; ENSP00000307077.2; ENSG00000171806.12. DR Ensembl; ENST00000310392.5; ENSP00000307975.4; ENSG00000171806.12. DR GeneID; 92342; -. DR KEGG; hsa:92342; -. DR MANE-Select; ENST00000310392.5; ENSP00000307975.4; NM_033418.4; NP_219486.1. DR UCSC; uc001ggn.6; human. DR AGR; HGNC:28793; -. DR CTD; 92342; -. DR DisGeNET; 92342; -. DR GeneCards; METTL18; -. DR HGNC; HGNC:28793; METTL18. DR HPA; ENSG00000171806; Low tissue specificity. DR MIM; 615255; gene. DR neXtProt; NX_O95568; -. DR OpenTargets; ENSG00000171806; -. DR PharmGKB; PA142672407; -. DR VEuPathDB; HostDB:ENSG00000171806; -. DR eggNOG; KOG2920; Eukaryota. DR GeneTree; ENSGT00390000000464; -. DR HOGENOM; CLU_038704_0_1_1; -. DR InParanoid; O95568; -. DR OMA; LCKCRFF; -. DR OrthoDB; 276605at2759; -. DR PhylomeDB; O95568; -. DR TreeFam; TF320884; -. DR PathwayCommons; O95568; -. DR SignaLink; O95568; -. DR BioGRID-ORCS; 92342; 27 hits in 1157 CRISPR screens. DR ChiTaRS; METTL18; human. DR GenomeRNAi; 92342; -. DR Pharos; O95568; Tdark. DR PRO; PR:O95568; -. DR Proteomes; UP000005640; Chromosome 1. DR RNAct; O95568; Protein. DR Bgee; ENSG00000171806; Expressed in primordial germ cell in gonad and 192 other cell types or tissues. DR ExpressionAtlas; O95568; baseline and differential. DR GO; GO:0005829; C:cytosol; IDA:UniProtKB. DR GO; GO:0005730; C:nucleolus; IDA:UniProtKB. DR GO; GO:0005634; C:nucleus; IDA:UniProtKB. DR GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB. DR GO; GO:0031072; F:heat shock protein binding; IPI:UniProtKB. DR GO; GO:0018064; F:protein-L-histidine N-tele-methyltransferase activity; IDA:UniProtKB. DR GO; GO:0018026; P:peptidyl-lysine monomethylation; IDA:UniProtKB. DR GO; GO:0090069; P:regulation of ribosome biogenesis; IMP:UniProtKB. DR GO; GO:2000232; P:regulation of rRNA processing; IMP:UniProtKB. DR GO; GO:0006417; P:regulation of translation; IMP:UniProtKB. DR GO; GO:0006448; P:regulation of translational elongation; IDA:UniProtKB. DR CDD; cd02440; AdoMet_MTases; 1. DR Gene3D; 3.40.50.150; Vaccinia Virus protein VP39; 1. DR InterPro; IPR019410; Methyltransf_16. DR InterPro; IPR029063; SAM-dependent_MTases_sf. DR PANTHER; PTHR14614; HEPATOCELLULAR CARCINOMA-ASSOCIATED ANTIGEN; 1. DR PANTHER; PTHR14614:SF39; HISTIDINE PROTEIN METHYLTRANSFERASE 1 HOMOLOG; 1. DR Pfam; PF13489; Methyltransf_23; 1. DR SUPFAM; SSF53335; S-adenosyl-L-methionine-dependent methyltransferases; 1. DR Genevisible; O95568; HS. PE 1: Evidence at protein level; KW 3D-structure; Cytoplasm; Methylation; Methyltransferase; Nucleus; KW Phosphoprotein; Reference proteome; S-adenosyl-L-methionine; Transferase. FT CHAIN 1..372 FT /note="Histidine protein methyltransferase 1 homolog" FT /id="PRO_0000247199" FT REGION 30..55 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 68..103 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 247..253 FT /note="Nuclear localization signal" FT /evidence="ECO:0000269|PubMed:33693809" FT COMPBIAS 35..55 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 68..91 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 168..172 FT /ligand="S-adenosyl-L-methionine" FT /ligand_id="ChEBI:CHEBI:59789" FT /evidence="ECO:0000269|Ref.14, ECO:0007744|PDB:4RFQ" FT BINDING 195 FT /ligand="S-adenosyl-L-methionine" FT /ligand_id="ChEBI:CHEBI:59789" FT /evidence="ECO:0000269|Ref.14, ECO:0000305|PubMed:35674491, FT ECO:0007744|PDB:4RFQ" FT BINDING 216..218 FT /ligand="S-adenosyl-L-methionine" FT /ligand_id="ChEBI:CHEBI:59789" FT /evidence="ECO:0000269|Ref.14, ECO:0007744|PDB:4RFQ" FT BINDING 268..270 FT /ligand="S-adenosyl-L-methionine" FT /ligand_id="ChEBI:CHEBI:59789" FT /evidence="ECO:0000269|Ref.14, ECO:0007744|PDB:4RFQ" FT BINDING 293 FT /ligand="S-adenosyl-L-methionine" FT /ligand_id="ChEBI:CHEBI:59789" FT /evidence="ECO:0000269|Ref.14, ECO:0007744|PDB:4RFQ" FT MOD_RES 72 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:17525332, FT ECO:0007744|PubMed:23186163" FT MOD_RES 77 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648, FT ECO:0007744|PubMed:23186163" FT MOD_RES 154 FT /note="Tele-methylhistidine; by autocatalysis" FT /evidence="ECO:0000269|PubMed:33693809" FT VARIANT 10 FT /note="E -> D (in dbSNP:rs10489177)" FT /id="VAR_027087" FT VARIANT 309 FT /note="F -> L (in dbSNP:rs34396097)" FT /id="VAR_054050" FT VARIANT 318 FT /note="R -> H (in dbSNP:rs35984232)" FT /id="VAR_054051" FT VARIANT 325 FT /note="A -> V (in dbSNP:rs16862686)" FT /id="VAR_027088" FT VARIANT 360 FT /note="K -> M (in dbSNP:rs13375701)" FT /id="VAR_027089" FT MUTAGEN 154 FT /note="H->A: No effect on automethylation. Loss of FT protein-L-histidine N-tele-methyltransferase activity FT toward RPL3." FT /evidence="ECO:0000269|PubMed:33693809" FT MUTAGEN 193..197 FT /note="DLGCG->KLRCR: Abolished protein-L-histidine FT N-tele-methyltransferase activity." FT /evidence="ECO:0000269|PubMed:35674491" FT MUTAGEN 217 FT /note="D->A: Loss of protein-L-histidine FT N-tele-methyltransferase activity." FT /evidence="ECO:0000269|PubMed:33693809" FT MUTAGEN 250..251 FT /note="KR->GG: Decreased localization to the nucleus." FT /evidence="ECO:0000269|PubMed:33693809" FT HELIX 86..88 FT /evidence="ECO:0007829|PDB:4RFQ" FT STRAND 92..94 FT /evidence="ECO:0007829|PDB:4RFQ" FT STRAND 101..103 FT /evidence="ECO:0007829|PDB:4RFQ" FT HELIX 109..113 FT /evidence="ECO:0007829|PDB:4RFQ" FT STRAND 116..120 FT /evidence="ECO:0007829|PDB:4RFQ" FT STRAND 124..126 FT /evidence="ECO:0007829|PDB:4RFQ" FT STRAND 130..138 FT /evidence="ECO:0007829|PDB:4RFQ" FT STRAND 162..164 FT /evidence="ECO:0007829|PDB:4RFQ" FT HELIX 170..181 FT /evidence="ECO:0007829|PDB:4RFQ" FT STRAND 190..194 FT /evidence="ECO:0007829|PDB:4RFQ" FT HELIX 200..207 FT /evidence="ECO:0007829|PDB:4RFQ" FT STRAND 211..218 FT /evidence="ECO:0007829|PDB:4RFQ" FT HELIX 220..225 FT /evidence="ECO:0007829|PDB:4RFQ" FT HELIX 227..233 FT /evidence="ECO:0007829|PDB:4RFQ" FT HELIX 257..262 FT /evidence="ECO:0007829|PDB:4RFQ" FT STRAND 263..268 FT /evidence="ECO:0007829|PDB:4RFQ" FT HELIX 270..278 FT /evidence="ECO:0007829|PDB:4RFQ" FT STRAND 280..283 FT /evidence="ECO:0007829|PDB:4RFQ" FT STRAND 287..294 FT /evidence="ECO:0007829|PDB:4RFQ" FT HELIX 299..301 FT /evidence="ECO:0007829|PDB:4RFQ" FT HELIX 302..312 FT /evidence="ECO:0007829|PDB:4RFQ" FT STRAND 313..326 FT /evidence="ECO:0007829|PDB:4RFQ" FT TURN 328..330 FT /evidence="ECO:0007829|PDB:4RFQ" FT HELIX 334..344 FT /evidence="ECO:0007829|PDB:4RFQ" FT STRAND 346..355 FT /evidence="ECO:0007829|PDB:4RFQ" FT STRAND 357..359 FT /evidence="ECO:0007829|PDB:4RFQ" FT STRAND 361..368 FT /evidence="ECO:0007829|PDB:4RFQ" SQ SEQUENCE 372 AA; 42148 MW; 3F0C1599035BA8B1 CRC64; MTFQFNFTIE DHLENELTPI RDGALTLDSS KELSVSESQK GEERDRKCSA EQFDLPQDHL WEHKSMENAA PSQDTDSPLS AASSSRNLEP HGKQPSLRAA KEHAMPKDLK KMLENKVIET LPGFQHVKLS VVKTILLKEN FPGENIVSKS FSSHSDLITG VYEGGLKIWE CTFDLLAYFT KAKVKFAGKK VLDLGCGSGL LGITAFKGGS KEIHFQDYNS MVIDEVTLPN VVANSTLEDE ENDVNEPDVK RCRKPKVTQL YKCRFFSGEW SEFCKLVLSS EKLFVKYDLI LTSETIYNPD YYSNLHQTFL RLLSKNGRVL LASKAHYFGV GGGVHLFQKF VEERDVFKTR ILKIIDEGLK RFIIEITFKF PG //